newsfilter
← Latest News
ACCESS Newswire·

Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025

NEWARK, CA / ACCESS Newswire / April 23, 2025 / Protagonist Therapeutics, Inc. announced that an abstract was accepted for presentation at the Plenary Session at the